| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.4M | +476.3% |
| SG&A Expense | $12.3M | +210.6% |
| Operating Income | -$28.7M | -321.3% |
| Net Income | -$28.8M | -223.7% |
| EPS (Basic) | -$0.98 | -11.4% |
| EPS (Diluted) | -$0.98 | -11.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $333K | -94.0% |
| Total Assets | $6.8M | +23.5% |
| Current Liabilities | $11.8M | +154.2% |
| Total Liabilities | $11.9M | +151.0% |
| Stockholders' Equity | -$6.1M | -16.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.2M | -95.5% |
| Investing Cash Flow | -$466K | — |
| Financing Cash Flow | $9.4M | -26.1% |